List of works - Andrea Bonetti

Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?

scientific article published on 19 June 2015

Ampulla of Vater carcinoma in real-world clinical practice: a case series.

scientific article published on 25 June 2015

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis

scientific article published on 01 January 1997

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.

scientific article

Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly.

scientific article

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

scientific article published on 12 February 2016

Cisplatin versus cetuximab given concomitantly with radiotherapy in non-resectable head and neck squamous cell carcinoma: an open question

scientific article published on 25 February 2015

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

scientific article

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

scientific article published on 23 December 2009

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.

scientific article published on 18 January 2015

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

scientific article published on 23 February 2015

Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice

scientific article published on 01 March 2017

Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs

scientific article

Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis

scientific article published on 01 January 1992

Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

scientific article published on October 2013

Hepatic artery infusion for liver metastases from colorectal cancer.

scientific article

High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.

scientific article published in June 1993

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

scientific article published on 11 April 2011

Late recurrence (more than 10 years) in early (tumors equal to or smaller than 2 cm) breast cancer patients

scientific article published on 30 October 2015

Management of advanced pancreatic cancer in daily clinical practice.

scientific article

Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs

scientific article published on 23 April 2017

Off-label prescription of anti-cancer drugs in Italy: what responsibilities?

scientific article published in July 2013

Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.

scientific article published on April 1998

Pharmacokinetics of an extended-release human interferon alpha-2b formulation

scientific article published on 01 January 1993

Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials

scientific article published on 17 December 2015

Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

scientific article published on 26 October 2015

Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question.

scientific article published on 24 July 2015

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial ⬇️

scientific article published on May 23, 2011

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

scientific article

Re: Michal Sarfaty, Moshe Leshno, Noa Gordon, et al. Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.07.041: Second-line Treatment in Metastatic Renal Cell Carcinoma. Can

scientific article published on 31 October 2017

Rhabdoid carcinoma of the colon: a distinct entity with a very aggressive behavior: a case report associated with a polyposis coli and review of the literature.

scientific article published on 26 July 2011

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

scientific article

Second-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer

scientific article published on 10 November 2015

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

scientific article published on 12 January 2017

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating e

scientific article published on 10 November 2016

The Multidisciplinary Management of Cancer in Daily Clinical Practice: Towards a Community Hospital Comprehensive Cancer Center.

scientific article published in March 2016

The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies

scientific article published on 04 September 2015

The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors.

scientific article published on 5 May 2016

The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials

scientific article

The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials

scientific article published on 19 July 2016

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.

scientific article

The effect of palliative care on the assistance of terminally ill cancer patients

scientific article published on 08 June 2013

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients treated with targeted agents.

scientific article

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials

scientific article

The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction

scientific article published on 29 January 2016

Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".

scientific article published in January 2015

Trends in survival for patients with metastatic breast cancer: is survival improving?

scientific article published on 30 April 2015

Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience.

scientific article published on 17 August 2011

List of works by Andrea Bonetti

Acute Liver Failure Caused by Metastatic Breast Cancer: Can We Expect Some Results from Chemotherapy?

Ampulla of Vater carcinoma in real-world clinical practice: a case series.

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.

Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly.

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

Cisplatin versus cetuximab given concomitantly with radiotherapy in non-resectable head and neck squamous cell carcinoma: an open question

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice

Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs

Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis

Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

Hepatic artery infusion for liver metastases from colorectal cancer.

High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

Late recurrence (more than 10 years) in early (tumors equal to or smaller than 2 cm) breast cancer patients

Management of advanced pancreatic cancer in daily clinical practice.

Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs

Off-label prescription of anti-cancer drugs in Italy: what responsibilities?

Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.

Pharmacokinetics of an extended-release human interferon alpha-2b formulation

Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials

Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question.

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial ⬇️

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

Re: Michal Sarfaty, Moshe Leshno, Noa Gordon, et al. Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.07.041: Second-line Treatment in Metastatic Renal Cell Carcinoma. Can

Rhabdoid carcinoma of the colon: a distinct entity with a very aggressive behavior: a case report associated with a polyposis coli and review of the literature.

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

Second-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating e

The Multidisciplinary Management of Cancer in Daily Clinical Practice: Towards a Community Hospital Comprehensive Cancer Center.

The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies

The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors.

The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials

The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials

The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.

The effect of palliative care on the assistance of terminally ill cancer patients

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients treated with targeted agents.

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials

The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction

Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".

Trends in survival for patients with metastatic breast cancer: is survival improving?

Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience.